金斯瑞生物-一千(01548)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01548 金斯瑞生物-一千

交易中 11-11 13:10:37

32.780

-1.040

-3.08%

最高34.420	最低31.380	成交量2,120万
今开32.700	昨收33.820	日振幅8.99%
总市值748.70亿	流通市值748.70亿	总股本22.84亿
成交额6.89亿	换手率0.93%	流通股本22.84亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01548","market":"HK","secType":"STK","nameCN":"金斯瑞生物-一千","latestPrice":32.78,"timestamp":1794373834223,"preClose":33.82,"halted":0,"volume":21201340,"delay":0,"changeRate":-0.030751034890597256,"floatShares":2284000000,"shares":2284000000,"eps":-0.2458,"marketStatus":"交易中","change":-1.04,"latestTime":"11-11 13:10:37","open":32.7,"high":34.42,"low":31.38,"amount":689045376,"amplitude":0.089888,"askPrice":32.78,"askSize":6000,"bidPrice":32.76,"bidSize":5000,"shortable":3,"etf":0,"ttmEps":-2.288748,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1794384600000},"marketStatusCode":2,"adr":0,"listingDate":1451404800000,"exchange":"SEHK","adjPreClose":33.82,"openAndCloseTimeList":[[1794360600000,1794369600000],[1794373200000,1794384000000]],"volumeRatio":0.988004,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01548","defaultTab":"news","newsList":[{"id":"2682838329","title":"港股异动 | 金斯瑞生物科技(01548.HK)早盘跌超6% 小摩指金斯瑞美国核酸筛查新规属可控问题","url":"https://stock-news.laohu8.com/highlight/detail?id=2682838329","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682838329?lang=zh_cn&edition=full","pubTime":"2026-11-11 10:45","pubTimestamp":1794365128,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HK0000320223.HKD","BK1576","HK0000320264.USD","HK0000306685.HKD","BK1583","01548","HK0000306701.USD","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143754942","title":"异动解读｜金斯瑞生物-一千盘中下跌3.61%，传奇生物披露第三季度业绩后市场反应分化","url":"https://stock-news.laohu8.com/highlight/detail?id=1143754942","media":"行情直击","labels":[],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143754942?lang=zh_cn&edition=full","pubTime":"2026-11-11 09:30","pubTimestamp":1794360650,"startTime":"0","endTime":"0","summary":"11月11日，金斯瑞生物-一千盘中下跌3.61%，报32.62港元，成交额1205.49万港元。消息面上，公司于前一日晚公告称，联营公司传奇生物已向美国证券交易委员会提交6-K文件，披露截至9月30日止第三季度财务业绩及近期业务亮点。公司同时强调，该次披露内容仅针对传奇生物，与金斯瑞生物-一千自身财务状况和经营业绩无直接对应关系。此前市场对公司催化更多集中于AIDD带动湿实验需求增长及机构上调预期，本次联营公司业绩披露后，资金情绪出现分化。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"金斯瑞生物盘中下挫，传奇生物业绩引发分歧","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100104905","title":"金斯瑞生物-一千（01548）公告：联营公司传奇生物已向SEC提交2026年第三季度业绩6-K文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1100104905","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100104905?lang=zh_cn&edition=full","pubTime":"2026-11-10 20:31","pubTimestamp":1794313901,"startTime":"0","endTime":"0","summary":"2026年11月10日，金斯瑞生物-一千（01548）发布自愿性公告称，其联营公司传奇生物科技股份有限公司已于2026年11月10日向美国证券交易委员会提交6-K表格，披露截至2026年9月30日止第三季度的财务业绩及近期业务亮点。\\n\\n传奇生物的股份以美国存托股份形式在美国纳斯达克全球精选市场上市。金斯瑞生物-一千在公告中提示，本次公布的财务数据和业务进展仅针对传奇生物，与本公司财务状况和经营业绩无直接对应关系。\\n\\n公司提醒全体股东及潜在投资者，投资决策需谨慎，并充分关注相关风险，在买卖或拟买卖本公司证券时保持审慎。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682293359","title":"港股异动 | 金斯瑞生物科技(01548.HK)早盘涨近12% 中国AI药物研发融资加速 大摩指金斯瑞受惠湿实验室需求","url":"https://stock-news.laohu8.com/highlight/detail?id=2682293359","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682293359?lang=zh_cn&edition=full","pubTime":"2026-11-10 10:12","pubTimestamp":1794276755,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01548","HK0000320264.USD","BK1576","BK1141","HK0000306701.USD","HK0000306685.HKD","HK0000320223.HKD","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176741945","title":"异动解读｜金斯瑞生物科技盘中上涨8.88%，机构看好AIDD驱动生命科学业务增长","url":"https://stock-news.laohu8.com/highlight/detail?id=1176741945","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176741945?lang=zh_cn&edition=full","pubTime":"2026-11-10 09:34","pubTimestamp":1794274465,"startTime":"0","endTime":"0","summary":"11月10日，金斯瑞生物科技盘中上涨8.88%，报34.48港元，成交额1.96亿港元。消息面上，机构最新研报称，公司在投资者日重点交流AIDD产业机遇、技术平台建设及长期增长战略，并上调盈利预期，带动市场继续交易AI制药催化下的生命科学业务扩张逻辑。公司预计未来三年生命科学AIDD潜在可服务市场复合增速50%-80%，AIDD将从新增客户、更快迭代周期、更高验证通量及更深层次湿实验需求四方面拉动订单；同板块药明康德、药明生物、晶泰控股、英矽智能同步走强，也强化了板块联动。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"金斯瑞生物大涨，AIDD驱动增长","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682987607","title":"金斯瑞生物科技（01548）涨超6% 机构看好AIDD赛道红利并上调其盈利预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2682987607","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682987607?lang=zh_cn&edition=full","pubTime":"2026-11-09 13:36","pubTimestamp":1794202580,"startTime":"0","endTime":"0","summary":"消息面上，华泰证券发布研报，金斯瑞生物科技于近期举办2026年投资者日，围绕AIDD产业机遇、技术平台建设、业务布局及长期增长战略展开交流。公司预计未来三年生命科学AIDD潜在可服务市场复合增速50%-80%，AIDD将从新增客户、更快迭代周期、更高验证通量、更深层次湿实验需求四方面拉动湿实验订单。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250110/NTQxOTRlZTU5ZGZkZjc4MmEzMTdjMTVhMTM1NjYxOTg3NzU=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NTQxOTRlZTU5ZGZkZjc4MmEzMTdjMTVhMTM1NjYxOTg3NzU=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1995531","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000320264.USD","BK1141","HK0000306701.USD","BK1576","HK0000320223.HKD","HK0000306685.HKD","BK1583","ZECP","01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682876428","title":"【券商聚焦】招银国际：中国创新药出海BD是核心动力","url":"https://stock-news.laohu8.com/highlight/detail?id=2682876428","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682876428?lang=zh_cn&edition=full","pubTime":"2026-11-09 13:15","pubTimestamp":1794201346,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际表示，2026年三季度，海外CXO和生命科学上游公司业绩延续逐季改善趋势，收入与调整后EPS中位数增速分别达+8.3%和+13.4%。生命科学上游改善最明显，CDMO受高基数影响增速放缓，临床前与临床CRO订单增长强劲，行业普遍上调全年指引。临床CRO订单维持增长，但可靠性受关注。生物药CDMO需求仍旺盛，但高基数致增速放缓。创新药融资三季度增速放缓，但2026全年预计实质性反弹，中国创新药出海BD是核心动力。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1995526","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0039217434.USD","LU0819121731.USD","BK1191","LU2399975544.HKD","02359","HK0000306685.HKD","LU0181495838.USD","LU1688375341.USD","02269","LU1242518931.SGD","LU0348825331.USD","HK0000320223.HKD","BK1576","06127","LU0572944931.SGD","03347","03759","HK0000306701.USD","IE00BFMHRM44.USD","LU0327786744.USD","KURE","LU0823426308.USD","LU0043850808.USD","BK1141","LU0456846285.SGD","LU1046422090.SGD","LU0516422440.USD","LU0128526141.USD","LU0149721374.USD","BK1610","LU0359202008.SGD","LU0501845795.SGD","01521","LU2039709279.SGD","LU2045819591.USD","LU0979878070.USD","LU0417516902.SGD","LU0540923850.HKD","01873","LU0072913022.USD","LU0348827113.USD","LU0051755006.USD","01548","06821","KCE","LU0359201612.USD","LU0455707207.USD","LU0856984785.SGD","LU0634319403.HKD","LU0320764599.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682013820","title":"港股异动 | 金斯瑞生物科技(01548.HK)涨超5% 机构看好AIDD驱动公司生命科学业务强劲增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2682013820","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682013820?lang=zh_cn&edition=full","pubTime":"2026-11-09 10:26","pubTimestamp":1794191191,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HK0000306701.USD","HK0000320223.HKD","01548","HK0000306685.HKD","HK0000320264.USD","BK1576","BK1141","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682820601","title":"生物医药板块走强 再鼎医药（09688）涨超13% 全球医药融资回暖支撑创新药与CXO景气上行","url":"https://stock-news.laohu8.com/highlight/detail?id=2682820601","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682820601?lang=zh_cn&edition=full","pubTime":"2026-11-09 10:08","pubTimestamp":1794190084,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药板块走强，截至发稿，再鼎医药 涨13.07%，康诺亚-B涨7.22%，康方生物涨6.33%，科伦博泰生物涨5.36%，药明生物涨4.96%，金斯瑞生物科技涨4.48%，复宏汉霖涨4.04%。2026年上半年，全球生物科技融资、License交易、并购交易金额分别达到502亿美元、1667亿美元和960亿美元，均显著超越去年上半年，医药融资及License交易持续回暖，为医药研发提供了资金支持。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1995489","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1588","LU0029874061.USD","SG9999002562.SGD","BK4581","02162","159938","LU1242518931.SGD","09939","LU0456846285.SGD","LU2039709279.SGD","02269","02696","399441","BK1610","CXO","IBBQ","09688","06990","LU0516423091.SGD","LU0543330566.HKD","LU0140636845.USD","LU0181495838.USD","XBI","LU0359201612.USD","LU0051755006.USD","KURE","LU1794554557.SGD","LU0196878994.USD","06978","LNGR","LU0456827905.SGD","09926","01548","LU1242518857.USD","WX","BK1583","161726","BK4588","HK0000165453.HKD","LU0320764243.SGD","LU0348767384.USD","LU0348825331.USD","LU0561508036.HKD","MEDX","LU0348784397.USD","159992","LU2476274308.USD","ZLAB","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197508380","title":"异动解读｜金斯瑞生物-一千盘中上涨3.29%，生命科学工具板块反弹带动修复","url":"https://stock-news.laohu8.com/highlight/detail?id=1197508380","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197508380?lang=zh_cn&edition=full","pubTime":"2026-11-09 09:54","pubTimestamp":1794189294,"startTime":"0","endTime":"0","summary":"11月9日，金斯瑞生物-一千盘中上涨3.29%，报31.38港元，成交额2.62亿港元。消息面上，近期公司已就股价异动及交易柜台传闻连续澄清，强调业务及营运维持正常；同时联营公司传奇生物披露，将于12月美国血液学会年会上展示CARVYKTI两场口头报告、两份海报及一篇电子出版物，市场对后续CAR-T研究进展仍在持续博弈。叠加同业药明生物、药明康德、英矽智能、晶泰控股、康龙化成集体走强，带动公司股价出现修复。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"金斯瑞生物上涨，CAR-T进展引关注","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681833331","title":"金斯瑞生物科技(01548)早盘跌超14% 成交额超8亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2681833331","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681833331?lang=zh_cn&edition=full","pubTime":"2026-11-06 10:57","pubTimestamp":1793933820,"startTime":"0","endTime":"0","summary":"11月6日，金斯瑞生物科技早盘跌超14%，截至发稿，跌9.09%，报30.62港元，成交额8.42亿港元。该股盘中最高触及31.14港元、最低下探至28.70港元，日内振幅达7.25%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611063924643657.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611063924643657.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["HK0000306701.USD","HK0000320264.USD","HK0000306685.HKD","BK1576","BK1583","BK1141","HK0000320223.HKD","01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109254946","title":"异动解读｜金斯瑞生物-一千盘中下跌13.54%，传奇生物ASH展示计划后资金继续博弈","url":"https://stock-news.laohu8.com/highlight/detail?id=1109254946","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109254946?lang=zh_cn&edition=full","pubTime":"2026-11-06 09:33","pubTimestamp":1793928799,"startTime":"0","endTime":"0","summary":"11月6日，金斯瑞生物-一千盘中下跌13.54%，报28.9港元，成交额1.75亿港元。消息面上，公司此前公告称联营公司传奇生物已提交6-K表格，并将于12月举行的美国血液学会年会上展示CARVYKTI治疗多发性骨髓瘤的两场口头报告、两份海报展示和一篇电子出版物。结合公司近日连续就股价异动及交易柜台传闻作出澄清、强调业务及营运维持正常，当前股价大幅波动，反映市场对后续CAR-T研究数据披露前的预期博弈与风险消化。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"金斯瑞盘中下跌，ASH数据前资金博弈","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103737911","title":"异动解读｜金斯瑞生物-一千盘中下跌3.24%，传奇生物将于ASH年会发布多项CAR-T研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1103737911","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103737911?lang=zh_cn&edition=full","pubTime":"2026-11-05 09:51","pubTimestamp":1793843506,"startTime":"0","endTime":"0","summary":"11月5日，金斯瑞生物-一千盘中下跌3.24%，报33.12港元，成交额2.46亿港元。消息面上，公司公告称其联营公司传奇生物已提交6-K表格，并将于12月举行的第68届美国血液学会年会上展示最新研究数据。该会议将于12月12日至15日在美国新奥尔良举行。结合公司此前连续就股价异动及交易柜台传闻作出澄清、强调业务营运维持正常，当前股价波动更多反映市场对后续CAR-T数据披露前的博弈与消化。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"金斯瑞生物异动下跌，传奇生物ASH数据将揭晓","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681091900","title":"金斯瑞生物科技(01548)：传奇宣布将于美国血液学会年会进行展示","url":"https://stock-news.laohu8.com/highlight/detail?id=2681091900","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681091900?lang=zh_cn&edition=full","pubTime":"2026-11-05 07:02","pubTimestamp":1793833339,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金斯瑞生物科技 发布公告，传奇生物科技股份有限公司于2026年11月4日向美国证券交易委员会提交6-K表格。并宣布将在于2026年12月12日至15日于美国路易斯安那州新奥尔良市举办的第68 届美国血液学会年会上，就CARVYKTI治疗多发性骨髓瘤的研究成果发表两场口头报告、两份海报展示和一篇电子出版物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1518737.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000306701.USD","HK0000320264.USD","BK1141","BK1576","BK1583","HK0000306685.HKD","HK0000320223.HKD","01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158825067","title":"金斯瑞生物-一千：传奇生物将于2026年ASH年会发布多项CAR-T研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1158825067","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158825067?lang=zh_cn&edition=full","pubTime":"2026-11-05 06:31","pubTimestamp":1793831462,"startTime":"0","endTime":"0","summary":"金斯瑞生物-一千11月5日公告称，其联营公司传奇生物科技股份有限公司已于2026年11月4日向美国证券交易委员会提交6-K表格，并公布将在第68届美国血液学会年会上展示最新研究数据。第68届ASH年会将于2026年12月12日至15日在美国路易斯安那州新奥尔良举行。公司提醒投资者关注传奇生物在美国证券交易委员会及公司官网发布的相关文件，并注意投资风险。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138396330","title":"异动解读｜金斯瑞生物科技盘中上涨3.84%，公司澄清关闭交易柜台传闻","url":"https://stock-news.laohu8.com/highlight/detail?id=1138396330","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138396330?lang=zh_cn&edition=full","pubTime":"2026-11-04 13:30","pubTimestamp":1793770258,"startTime":"0","endTime":"0","summary":"11月4日，金斯瑞生物科技盘中上涨3.84%，报31.38港元，成交额7.87亿港元。催化因素来自公司就近期股价异动发布澄清公告，明确所谓关闭交易柜台仅涉及每手2000股的临时柜台按更改每手买卖单位安排于11月4日下午4时10分关闭，并非关闭全部交易柜台；同时公司表示集团业务及营运维持正常，业务管理及财务状况并无重大变化。金斯瑞生物科技股份有限公司是一家主要从事生产及销售生命科学研究产品及服务的投资控股公司。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"金斯瑞生物科技上涨，澄清关闭交易柜台传闻","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680702367","title":"港股异动 | 金斯瑞生物科技(01548.HK)高开逾4% 公司澄清交易柜台传闻 集团业务及营运维持正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2680702367","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680702367?lang=zh_cn&edition=full","pubTime":"2026-11-04 09:25","pubTimestamp":1793755549,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1576","HK0000320223.HKD","BK1583","HK0000306685.HKD","01548","HK0000306701.USD","HK0000320264.USD","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680774240","title":"金斯瑞生物科技(01548)：股份价格不寻常波动 不知悉波动原因","url":"https://stock-news.laohu8.com/highlight/detail?id=2680774240","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680774240?lang=zh_cn&edition=full","pubTime":"2026-11-03 18:57","pubTimestamp":1793703444,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金斯瑞生物科技 发布公告，本公司董事会注意到本公司股份的价格近期有不寻常波动。近期，本公司已于2026年10月30日成功举办2026年度投资者开放日活动。本集团的业务及营运维持正常，且在业务管理及财务状况方面并无重大变化。经本公司作出于有关情况下属合理的查询后，董事会确认，截至本公告日期，除本公告所披露者外，董事会并不知悉股份价格波动的任何原因，亦不知悉根据证券及期货条例第XIVA部须披露的任何内幕消息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1517897.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","HK0000306685.HKD","01548","HK0000320264.USD","BK1583","BK1576","HK0000320223.HKD","HK0000306701.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139536881","title":"金斯瑞生物-一千（01548）就股价异动发布澄清　每手买卖单位10月14日由2,000股改为1,000股","url":"https://stock-news.laohu8.com/highlight/detail?id=1139536881","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1139536881?lang=zh_cn&edition=full","pubTime":"2026-11-03 18:56","pubTimestamp":1793703361,"startTime":"0","endTime":"0","summary":"金斯瑞生物科技股份有限公司11月3日发布自愿性公告称，公司注意到其股份近期出现不寻常波动。董事会强调，除已公布事项外，并未知悉导致股价波动的其他原因，也没有根据《证券及期货条例》第XIVA部须予披露的任何内幕消息。公司指出，此次仅涉及每手买卖单位由2,000股调整为1,000股；以2,000股为每手的临时柜台将于2026年11月4日16时10分关闭，并非关闭全部交易柜台。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680878740","title":"金斯瑞生物科技：澄清关闭交易柜台传闻 业务营运维持正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2680878740","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680878740?lang=zh_cn&edition=full","pubTime":"2026-11-03 18:55","pubTimestamp":1793703300,"startTime":"0","endTime":"0","summary":"南财智讯11月3日电，金斯瑞生物科技（01548.HK）发布自愿公告，公司董事会注意到近期股份价格存在不寻常波动。针对某财经媒体指称公司将关闭交易柜台的传闻，公司澄清称，以2000股为每手买卖单位的临时柜台将于2026年11月4日下午4时10分关闭，此为更改每手买卖单位（由2000股更改为1000股）的正常安排。公司表示，业务及营运维持正常，无重大变化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611033920397991.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611033920397991.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["HK0000320264.USD","HK0000306701.USD","HK0000306685.HKD","HK0000320223.HKD","01548","BK1576","BK1141","BK1583"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.genscript.com","stockEarnings":[{"period":"1week","weight":0.1191},{"period":"1month","weight":-0.2024},{"period":"3month","weight":0.3604},{"period":"6month","weight":1.326},{"period":"1year","weight":1.0928},{"period":"ytd","weight":1.723}],"compareEarnings":[{"period":"1week","weight":0.0438},{"period":"1month","weight":0.0143},{"period":"3month","weight":-0.0347},{"period":"6month","weight":-0.0694},{"period":"1year","weight":-0.0785},{"period":"ytd","weight":-0.0419}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"金斯瑞生物科技股份有限公司是一家主要从事生产及销售生命科学研究产品及服务的投资控股公司。该公司通过五个分部开展业务。生命科学服务及产品分部提供全面的研究服务及产品。生物制剂开发服务分部以一个综合平台提供全面服务，旨在帮助生物制药及生物技术公司加快治疗性抗体及基因、细胞疗法产品的开发。工业合成生物产品分部通过使用基因工程建构非病源微生物株，提供工业酶开发和生产。细胞疗法分部发现和开发用于治疗液体及固体肿瘤的CAR-T疗法。经营管理分部主要为其他分部提供共享服务。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.000341},{"month":2,"riseRate":0.545455,"avgChangeRate":0.075475},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.060575},{"month":4,"riseRate":0.545455,"avgChangeRate":0.057883},{"month":5,"riseRate":0.454545,"avgChangeRate":0.061694},{"month":6,"riseRate":0.545455,"avgChangeRate":0.030877},{"month":7,"riseRate":0.636364,"avgChangeRate":0.112261},{"month":8,"riseRate":0.454545,"avgChangeRate":0.171691},{"month":9,"riseRate":0.454545,"avgChangeRate":-0.035935},{"month":10,"riseRate":0.545455,"avgChangeRate":0.067257},{"month":11,"riseRate":0.545455,"avgChangeRate":0.037886},{"month":12,"riseRate":0.3,"avgChangeRate":0.042047}],"exchange":"SEHK","name":"金斯瑞生物-一千","nameEN":"GENSCRIPT B-1K"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"金斯瑞生物-一千(01548)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供金斯瑞生物-一千(01548)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"金斯瑞生物-一千,01548,金斯瑞生物-一千股票,金斯瑞生物-一千股票老虎,金斯瑞生物-一千股票老虎国际,金斯瑞生物-一千行情,金斯瑞生物-一千股票行情,金斯瑞生物-一千股价,金斯瑞生物-一千股市,金斯瑞生物-一千股票价格,金斯瑞生物-一千股票交易,金斯瑞生物-一千股票购买,金斯瑞生物-一千股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"金斯瑞生物-一千(01548)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供金斯瑞生物-一千(01548)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}